da Silva HA, Sitta A, Barschak AG, Deon M, Barden AT, Schmitt GO, et al
CMS.gov, Medicare GLP-1 Bridge Program announcement Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and cardiovascular risk reduction in adults with established CVD it is not a diabetes drug, unlike Ozempic
doi:10.1111/dom.12926
When Side Effects Require Medical Attention Severe or persistent vomiting, signs of dehydration (dark urine, dizziness, extreme thirst), or signs of pancreatitis (severe upper abdominal pain radiating to the back, fever) require immediate medical attention
PMID 31408289 4.Testosterone replacement therapy and spermatogenesis in reproductive age men
It also asks about your insurance plan, including your current deductible and whether your insurer offers GLP-1 medication coverage